Company intelligence
Desentum Oy
Imagine a world without allergies
Pharmaceutical Manufacturing
Espoo, FI
14 employees
Founded 2011
1 public signals
About Desentum Oy
Desentum is a research-oriented, clinical-stage biopharmaceutical company specialized in developing innovative allergen immunotherapy products that are based on switching the immune system’s response to allergens from hypersensitivity to tolerance. The goal is to provide long-term relief for patients suffering from allergic symptoms. Desentum’s product development targets both respiratory and food allergens. Our goal is to provide long-term relief from allergic symptoms with only a few months of treatment, as well as reduce the social and economic burden allergies cause to both individuals and society.
Verified activity
Signals from Desentum Oy
1 published signal